Encellin is a biotechnology company developing diabetes therapeutics using insulin responsive cells.
1
Funding Rounds
$5.9m
Money raised
Access comprehensive data and insights available only to Seedtable members
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
Name | Phone | Social networks | |
---|---|---|---|
Gr*** We* |
|
- | - |
Cr***** Ny***** |
|
- | linkedin twitter |
The company Encellin has raised a total of $5.9m in funding over 1 rounds.